De Ruysscher D - Search Results

1

Outcome after PORT in ypN2 or R1/R2 versus no PORT in ypN0 Stage III-N2 NSCLC after Induction Chemotherapy and Resection.

Billiet C, Peeters S, Decaluwé H, Vansteenkiste J, Dooms C, Deroose CM, Hendrikx M, De Leyn P, Bulens P, Karim R, Le Péchoux C, Mebis J, De Ruysscher D. Billiet C, et al. Among authors: de leyn p, de ruysscher d. J Thorac Oncol. 2016 Nov;11(11):1940-1953. doi: 10.1016/j.jtho.2016.06.018. Epub 2016 Jul 5. J Thorac Oncol. 2016. PMID: 27393474 Free article.

2

Sequential treatment with vindesine-ifosfamide-platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: a phase II trial.

Van den Brande P, De Ruysscher D, Vansteenkiste J, Spaas P, Specenier P, Demedts M. Van den Brande P, et al. Among authors: de ruysscher d. Lung Cancer. 1998 Oct;22(1):45-53. doi: 10.1016/s0169-5002(98)00071-3. Lung Cancer. 1998. PMID: 9869107 Clinical Trial.

3

Chest radiotherapy in limited-stage small cell lung cancer: facts, questions, prospects.

De Ruysscher D, Vansteenkiste J. De Ruysscher D, et al. Radiother Oncol. 2000 Apr;55(1):1-9. doi: 10.1016/s0167-8140(00)00156-0. Radiother Oncol. 2000. PMID: 10788682 Review.

4

Dose-intensified accelerated vindesine-ifosfamide-cisplatin (VIP) chemotherapy followed by high-dose accelerated hyperfractionated radiotherapy in patients with pathologically proven stage IIIB non-small cell lung cancer: a feasibility study.

De Ruysscher D, Lievens Y, Van den Brande P, Nackaerts K, Vansteenkiste J. De Ruysscher D, et al. Radiother Oncol. 2002 Jul;64(1):33-6. doi: 10.1016/s0167-8140(02)00144-5. Radiother Oncol. 2002. PMID: 12208572

5

Early versus late chest radiotherapy for limited stage small cell lung cancer.

Pijls-Johannesma MC, De Ruysscher D, Lambin P, Rutten I, Vansteenkiste JF. Pijls-Johannesma MC, et al. Among authors: de ruysscher d. Cochrane Database Syst Rev. 2005 Jan 25;2004(1):CD004700. doi: 10.1002/14651858.CD004700.pub2. Cochrane Database Syst Rev. 2005. PMID: 15674960 Free PMC article. Review.

6

Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.

van Der Wel A, Nijsten S, Hochstenbag M, Lamers R, Boersma L, Wanders R, Lutgens L, Zimny M, Bentzen SM, Wouters B, Lambin P, De Ruysscher D. van Der Wel A, et al. Among authors: de ruysscher d. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):649-55. doi: 10.1016/j.ijrobp.2004.06.205. Int J Radiat Oncol Biol Phys. 2005. PMID: 15708242

7

Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer.

De Ruysscher D, Pijls-Johannesma M, Vansteenkiste J, Kester A, Rutten I, Lambin P. De Ruysscher D, et al. Ann Oncol. 2006 Apr;17(4):543-52. doi: 10.1093/annonc/mdj094. Epub 2005 Dec 12. Ann Oncol. 2006. PMID: 16344277 Free article. Review.

8

Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer.

De Ruysscher D, Pijls-Johannesma M, Bentzen SM, Minken A, Wanders R, Lutgens L, Hochstenbag M, Boersma L, Wouters B, Lammering G, Vansteenkiste J, Lambin P. De Ruysscher D, et al. J Clin Oncol. 2006 Mar 1;24(7):1057-63. doi: 10.1200/JCO.2005.02.9793. J Clin Oncol. 2006. PMID: 16505424

9

Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients.

van Baardwijk A, Bosmans G, Dekker A, van Kroonenburgh M, Boersma L, Wanders S, Ollers M, Houben R, Minken A, Lambin P, De Ruysscher D. van Baardwijk A, et al. Among authors: de ruysscher d. Radiother Oncol. 2007 Feb;82(2):145-52. doi: 10.1016/j.radonc.2007.01.007. Epub 2007 Jan 26. Radiother Oncol. 2007. PMID: 17258339

10

Need for a new trial to evaluate adjuvant postoperative radiotherapy in non-small-cell lung cancer patients with N2 mediastinal involvement.

Le Péchoux C, Dunant A, Pignon JP, De Ruysscher D, Mornex F, Senan S, Casas F, Price A, Milleron B. Le Péchoux C, et al. Among authors: de ruysscher d. J Clin Oncol. 2007 Mar 1;25(7):e10-1. doi: 10.1200/JCO.2006.09.6263. J Clin Oncol. 2007. PMID: 17327597 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

511 results

Search Page

Filters